Wollenberg, A., de Bruin-Weller, M., Thyssen, J.P., Beck, L.A., Simpson, E.L., Imafuku, S., Boguniewicz, M., Kurbasic, A., Soldbro, L., Strange Vest, N., Arlert, P. and Paller, A.S. 2022. Conjunctivitis in adolescent patients aged 12–17 with moderate-to-severe atopic dermatitis treated with tralokinumab up to week 52: results from the phase 3 ECZTRA 6 trial. SKIN The Journal of Cutaneous Medicine. 6, 6 (Nov. 2022), s75. DOI:https://doi.org/10.25251/skin.6.supp.75.